US Patent Issued to Dicerna Pharmaceuticals on March 3 for "Methods for treating hepatitis B infection" (Massachusetts Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,601, issued on March 3, was assigned to Dicerna Pharmaceuticals Inc. (Lexington, Mass.).

"Methods for treating hepatitis B infection" was invented by Martin Koser (Lexington, Mass.) and Marc Abrams (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections."

The patent was filed on Feb. 2, 2022, under Application No. 17/649,781.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co...